Literature DB >> 22235056

Oily adjuvants and autoimmunity: now time for reconsideration?

M Whitehouse1.   

Abstract

Immunologists have relied heavily on oil-based adjuvants to generate antibodies or induce auto-allergic responses in experimental animals. These are rarely used today for human vaccination because of their persistent irritancies and propensity to cause ulcers at sites of injection. However oily materials with adjuvant properties abound in our modern environment, both personal and extraneous. Their inadvertent impact as cryptotoxins may contribute to the rising incidence of auto-allergic diseases in recent times. Experimentally, the potential adjuvanticity of various oils, fats and other lipids can be evaluated by their ability (or otherwise) to induce auto-allergic disease(s) in rats and mice with, or even without, the addition of a mycobacterial immunostimulant. Genetic factors have been recognized that determine an animal's susceptibility or resistance to these oil-induced immunopathies. So it may be profitable to further characterize these factors, first in animals and then perhaps in human populations, to help find ways to enhance natural resistance to those adjuvant-active oils that may be widely distributed in the personal environment, notably mineral oil(s). (The six tables in this article summarize some relevant facts and a few conjectures.) A caveat: This review is restricted to the adjuvant properties of some oils in the personal environment. It does not cover the mechanisms of adjuvanticity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235056     DOI: 10.1177/0961203311429818

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

Review 1.  Rapidly progressive diffuse systemic sclerosis after local vitamins A, D and E complex injections: literature review and report of two cases.

Authors:  Gustavo Guimarães Moreira Balbi; Ricardo Azêdo Montes; Verônica Silva Vilela; Marcella Azevedo Borges Andrade; Monisa Martins Nóbrega; Luna Azulay-Abulafia; Roberto Souto da Silva; Evandro Mendes Klumb; Roger Abramino Levy
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 2.  Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin®) and metallic silver.

Authors:  Michael Whitehouse; Desley Butters; Barrie Vernon-Roberts
Journal:  Inflammopharmacology       Date:  2013-05-19       Impact factor: 4.473

3.  Chitosan nanoparticle encapsulated hemagglutinin-split influenza virus mucosal vaccine.

Authors:  Chompoonuch Sawaengsak; Yasuko Mori; Koichi Yamanishi; Ampol Mitrevej; Nuttanan Sinchaipanid
Journal:  AAPS PharmSciTech       Date:  2013-12-17       Impact factor: 3.246

4.  Methylated BSA mimics amyloid-related proteins and triggers inflammation.

Authors:  Jeremy Di Domizio; Stephanie Dorta-Estremera; Wei Cao
Journal:  PLoS One       Date:  2013-05-01       Impact factor: 3.240

5.  Adjuvants- and vaccines-induced autoimmunity: animal models.

Authors:  Jiram Torres Ruiz; Luis Luján; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 4.505

6.  Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis.

Authors:  Cheri L Lubahn; Dianne Lorton; Jill A Schaller; Sarah J Sweeney; Denise L Bellinger
Journal:  Front Immunol       Date:  2014-08-11       Impact factor: 7.561

7.  Reducing lesion incidence in pork carcasses by heating foot-and-mouth disease vaccine before injection.

Authors:  Jaesung Cho; Eun Young Ko; Kyung Jo; Seonmin Lee; Sungbong Jang; Minho Song; Samooel Jung
Journal:  Asian-Australas J Anim Sci       Date:  2019-08-03       Impact factor: 2.509

8.  Adverse events following immunization with vaccines containing adjuvants.

Authors:  S Cerpa-Cruz; P Paredes-Casillas; E Landeros Navarro; A G Bernard-Medina; G Martínez-Bonilla; S Gutiérrez-Ureña
Journal:  Immunol Res       Date:  2013-07       Impact factor: 4.505

Review 9.  Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs.

Authors:  Nikolai Petrovsky
Journal:  Drug Saf       Date:  2015-11       Impact factor: 5.606

Review 10.  The ASIA syndrome: basic concepts.

Authors:  Abdulla Watad; Kassem Sharif; Yehuda Shoenfeld
Journal:  Mediterr J Rheumatol       Date:  2017-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.